Oncology Letters · 2013 · 25 citations · 16 references
MedicineCell BiologyOncologyBiocompatibilityCancer Drug Toxicity ManagementSurgical OncologyAdjuvant TherapyCytotoxicity AssessmentCytotoxicity EvaluationMalignant NeoplasmsTumor BiologyAdjuvant UseCytotoxicity AssaysGiant Cell LesionsPhenol ToxicityTissue Damage MechanismsTissue PenetrationTissue Penetration EfficiencyTumor Penetration
Local adjuvant treatment of giant cell tumours (GCTs) of the bone with phenol has led to a significant reduction in recurrence rates. In the current study, the optimal phenol concentration and duration of intralesional exposure were evaluated. Specimens of GCTs were exposed to various concentrations of phenol solution (6, 60 and 80%) for either 1 or 3 min. Following embedding in glutaraldehyde, the tumour cell layers were examined by transmission electron microscopy. Destroyed cell organelles indicated the penetration depth as a sign of denaturation. Incubation of GCT specimens with 6% phenol solution for 3 min resulted in the most tissue damage and the deepest tissue penetration of ~200 µm. Incubation with 60 and 80% phenol solution reached a penetration depth of only ~100 µm. Phenol instillation may be used for the treatment of small scattered cellular debris following intralesional curettage; however, it is not suitable for treatment of remaining solid tumour tissue of GCT. The use of high phenol concentrations has no benefit and increases the risk of local or systemic intoxication.
16
Mario Campanacci, Nicola Baldini, Stefano Boriani et al. · PubMed · 1987 · 1.3K citations
Mario Campanacci, Nicola Baldini, Stefano Boriani et al. · Journal of Bone and Joint Surgery · 1987 · 1K citations
Giant Cell Tumor of Long Bone: A Canadian Sarcoma Group Study
Robert Turcotte, Jay S. Wunder, Marc Isler et al. · Clinical Orthopaedics and Related Research · 2002 · 354 citations
M Szendröi · PubMed · 2004 · 351 citations